These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19324447)
1. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Bieniasz M; Oszajca K; Eusebio M; Kordiak J; Bartkowiak J; Szemraj J Lung Cancer; 2009 Dec; 66(3):319-26. PubMed ID: 19324447 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis. Bonnesen B; Pappot H; Holmstav J; Skov BG Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448 [TBL] [Abstract][Full Text] [Related]
3. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis]. Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444 [TBL] [Abstract][Full Text] [Related]
4. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657 [TBL] [Abstract][Full Text] [Related]
5. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer. Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543 [TBL] [Abstract][Full Text] [Related]
6. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214 [TBL] [Abstract][Full Text] [Related]
7. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer. Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074 [TBL] [Abstract][Full Text] [Related]
15. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Langenfeld EM; Calvano SE; Abou-Nukta F; Lowry SF; Amenta P; Langenfeld J Carcinogenesis; 2003 Sep; 24(9):1445-54. PubMed ID: 12819188 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer. Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135 [TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer. Nakashima T; Huang CL; Liu D; Kameyama K; Masuya D; Ueno M; Haba R; Yokomise H Med Sci Monit; 2004 Jun; 10(6):BR157-65. PubMed ID: 15173661 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]